Chemoinformaics analysis of Glutaric acid, decyl 2,5-difluorobenzyl ester
| Molecular Weight | 398.49 | nRot | 15 |
| Heavy Atom Molecular Weight | 366.234 | nRig | 8 |
| Exact Molecular Weight | 398.227 | nRing | 1 |
| Solubility: LogS | -6.337 | nHRing | 0 |
| Solubility: LogP | 6.137 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 62.3994 |
| nHD | 0 | BPOL | 39.5366 |
| QED | 0.274 |
| Synth | 2.157 |
| Natural Product Likeliness | -0.611 |
| NR-PPAR-gamma | 0.61 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.987 |
| Pgp-sub | 0.001 |
| HIA | 0.001 |
| CACO-2 | -4.811 |
| MDCK | 0.0000216 |
| BBB | 0.229 |
| PPB | 0.973676 |
| VDSS | 0.903 |
| FU | 0.0134235 |
| CYP1A2-inh | 0.822 |
| CYP1A2-sub | 0.17 |
| CYP2c19-inh | 0.726 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.646 |
| CYP2c9-sub | 0.816 |
| CYP2d6-inh | 0.407 |
| CYP2d6-sub | 0.115 |
| CYP3a4-inh | 0.738 |
| CYP3a4-sub | 0.142 |
| CL | 9.624 |
| T12 | 0.27 |
| hERG | 0.267 |
| Ames | 0.029 |
| ROA | 0.202 |
| SkinSen | 0.806 |
| Carcinogencity | 0.146 |
| EI | 0.137 |
| Respiratory | 0.165 |
| NR-Aromatase | 0.174 |
| Antiviral | Yes |
| Prediction | 0.802794 |